10x Genomics (TXG) Inventory (2018 - 2026)

10x Genomics has disclosed Inventory across 9 years of filings, most recently posting $52.6 million for Q2 2026.

• In Q2 2026, Inventory fell 23.71% year-over-year to $52.6 million; the TTM figure through Jun 2026 stood at $52.6 million (down 23.71% YoY), while the FY2025 annual figure was $56.3 million, down 32.21% from the prior year.
• Inventory came in at $52.6 million for Q2 2026 at 10x Genomics, down from $53.5 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $94.0 million in Q3 2024 to a low of $52.6 million in Q2 2026.
• Average Inventory over 5 years is $74.0 million, with a median of $76.7 million recorded in 2022.
• Year-over-year, Inventory jumped 65.42% in 2022 and tumbled 34.12% in 2025.
• Over 5 years, Inventory stood at $81.6 million in 2022, then dropped by 9.71% to $73.7 million in 2023, then grew by 12.75% to $83.1 million in 2024, then tumbled by 32.21% to $56.3 million in 2025, then slipped by 6.61% to $52.6 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $52.6 million in Q2 2026, $53.5 million in Q1 2026, and $56.3 million in Q4 2025.